Sionna Therapeutics, Inc. (SION) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 220.96M | 241.42M | 252.33M | 266.75M | 273.68M | 150.99M | 140.34M | 39.21M |
| Cash & Short-Term Investments | 216.15M | 235.88M | 248.33M | 262.57M | 269.67M | 147.54M | 137.47M | 38.52M |
| Cash Only | 63.32M | 58.45M | 50.83M | 40.98M | 82.69M | 37.79M | 35.75M | 38.52M |
| Short-Term Investments | 152.83M | 177.43M | 197.5M | 221.59M | 186.97M | 109.75M | 101.72M | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.81M | 5.54M | 4M | 4.17M | 4.01M | 3.46M | 2.86M | 686K |
| Total Non-Current Assets | 84.08M | 84.53M | 86.94M | 85.3M | 95.99M | 34.76M | 56.93M | 12.74M |
| Property, Plant & Equipment | 8.75M | 9.15M | 9.31M | 9.64M | 10.01M | 10.3M | 10.65M | 11.73M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 74.42M | 77.63M | 75.66M | 85.02M | 20.5M | 43.4M | 0 |
| Other Non-Current Assets | 75.33M | 963K | 0 | 0 | 962K | 3.96M | 2.88M | 1.01M |
| Total Assets | 305.04M | 325.95M | 339.27M | 352.05M | 369.67M | 185.75M | 197.26M | 51.95M |
| Asset Turnover | - | - | - | - | - | - | - | - |
| Asset Growth % | -17.48% | 75.48% | 71.99% | - | - | 257.59% | - | - |
| Total Current Liabilities | 9.78M | 11.71M | 9.85M | 7.55M | 9.53M | 10.42M | 6.48M | 8.04M |
| Accounts Payable | 2.11M | 769K | 1.48M | 914K | 5.02M | 1.19M | 104K | 719K |
| Days Payables Outstanding | 840.97 | 680.92 | - | 1.84K | - | - | - | - |
| Short-Term Debt | 1.32M | 0 | 1.22M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.34M | 4.75M | 4.09M | 3.48M | 989K | 2.97M | 2.03M | 3.11M |
| Current Ratio | 22.60x | 20.61x | 25.61x | 35.33x | 28.73x | 14.49x | 21.66x | 4.88x |
| Quick Ratio | 22.60x | 20.61x | 25.61x | 35.33x | 28.73x | 14.49x | 21.66x | 4.88x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.05M | 7.41M | 7.75M | 8.07M | 8.38M | 339.05M | 339.34M | 158.79M |
| Long-Term Debt | 7.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 7.41M | 7.75M | 8.07M | 8.38M | 8.68M | 8.97M | 9.75M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 330.37M | 330.37M | 149.04M |
| Total Liabilities | 16.83M | 19.12M | 17.6M | 15.62M | 17.91M | 349.46M | 345.81M | 166.83M |
| Total Debt | 8.38M | 8.68M | 8.97M | 9.24M | 9.5M | 9.75M | 9.99M | 10.48M |
| Net Debt | -54.95M | -49.77M | -41.86M | -31.75M | -73.2M | -28.04M | -25.75M | -28.04M |
| Debt / Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | 288.21M | 306.83M | 321.67M | 336.43M | 351.77M | -163.71M | -148.55M | -114.88M |
| Equity Growth % | -18.07% | 287.42% | 316.54% | - | - | -42.51% | - | - |
| Book Value per Share | 6.42 | 7.68 | 7.23 | 7.62 | 7.98 | -3.71 | -3.37 | -2.60 |
| Total Shareholders' Equity | 288.21M | 306.83M | 321.67M | 336.43M | 351.77M | -163.71M | -148.55M | -114.88M |
| Common Stock | 45K | 45K | 44K | 44K | 44K | 5K | 5K | 2K |
| Retained Earnings | -283.13M | -256.35M | -235.91M | -215.64M | -197.57M | -181.09M | -165.24M | -119.4M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -84K | 540K | 420K | 183K | 301K | 368K | 773K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |